Purchase Order 75N94018P00650
- Not listed
- This federal contract award to Bioqual, Inc. was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $3,500 firm fixed-price purchase order is to support the recovery of blood from SIV-positive rhesus macaques treated with BrdU (bromodeoxyuridine). This work is likely connected to NIAID's nonhuman primate (NHP) research programs, which utilize animal models to study viral infections and develop...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $64,800.00 firm fixed-price purchase order to Bioqual, Inc., a for-profit organization, to collect rhesus macaque blood, bone marrow, and tissue with HIV-1 envelopes. This is an extension of an ongoing project with a period of performance from August 15, 2018 to March 31, 2019. The award was made on a sole-source basis, as Bioqual was determined...
- This is a $127,482.01 firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bioqual, Inc., a small business prime contractor, for the "MONKEY CURE STUDY 2" project. The contract has a completion date of July 31, 2020. Bioqual, a fully accredited company that provides animal research services, has received multiple prime contracts and subcontracts from federal agencies like the National Institutes of Health and Uniformed...
- This is a $22,349 firm-fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases to Bioqual, Inc. for biomedical research services. Bioqual, a prime contractor, will provide animal studies, laboratory analysis, and animal housing and care support. The contract is not set-aside and has a period of performance ending on September 16, 2020. Bioqual holds two larger indefinite-delivery contracts with the National Institute of Allergy and...
- This firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, provides for the housing and maintenance of non-human primates. The $646,000.00 contract was awarded to Bioqual, Inc., a for-profit organization that serves as a prime contractor and subcontractor on federal research projects. Bioqual has experience supporting biomedical research through federal contracts, including providing animal study...
- This is a $544,999.84 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bioqual, Inc. for the housing and maintenance of non-human primates. The contract is not set aside. Bioqual is a prime contractor that provides facilities, research scientists, veterinarians, and animal care personnel to support biomedical research, including conducting animal studies, providing...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases to Bioqual, Inc., a for-profit organization, on August 29, 2017. The contract, valued at $145,225.00, is for the development of an HIV drug candidate. No set-aside was used. As a prime contractor to the NIH, Bioqual conducts animal studies, provides laboratory analysis services, and houses...
- This is a $399,995.93 firm-fixed-price delivery order federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a small business. The contract is for the housing and maintenance of laboratory animals, specifically non-human primates, in support of NIAID's Vaccine Research Center (VRC). The contract is set aside for small businesses and is issued under NIAID's Simian Vaccine Evaluation Units (SVEU)...
- This is a $2,046,067.33 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Bioqual, Inc. for "MODEL REFINEMENT IN PIGTAILED MACAQUES". The contract is part of NIAID's Animal Models of Infectious Diseases 2010-2017 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Bioqual, as the prime contractor, will provide research services and support related to animal studies, specifically involving pigtailed...
- This contract was awarded by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Bioqual, Inc., a for-profit organization, to provide other functions related to rhesus macaque blood, bone marrow, and tissue with HIV-1 envelopes. The $396,492.00 firm fixed price contract has a completion date of July 10, 2018 and was awarded on July 11, 2017. Bioqual has received prior prime contracts and subcontracts from NIH and other agencies to support...
This firm fixed price purchase order for $197,737 was awarded by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to Bioqual, Inc. to conduct a 190-day in vivo study of Nipamovir in rhesus macaques. Under the contract, Bioqual will acquire and maintain infected monkeys, administer the test compound according to an agreed-upon protocol, collect samples and measurements, provide biweekly status reports and a draft final report to the NIDDK investigator for review. The study aims to further evaluate the candidate's mechanism for inactivating HIV through non-human primate testing, in support of assembling a regulatory package for an Investigational New Drug Application to the U.S. Food and Drug Administration.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Nipamovir in vivo study in rhesus macaques. | NICHD-18-116 | Department of Health and Human Services National Institutes of Health | Pre-Solicitation 1/1 | 8/26/18, 8:57 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $197.7k | 8/31/18 |